34 research outputs found

    Make it personal: a social explanation system applied to group recommendations

    Get PDF
    Recommender systems help users to identify which items from a variety of choices best match their needs and preferences. In this context, explanations act as complementary information that can help users to better comprehend the system’s output and to encourage goals such as trust, confidence in decision-making or utility. In this paper we propose a Personalized Social Individual Explanation approach (PSIE). Unlike other expert systems the PSIE proposal novelly includes explanations about the system’s group recommendation and explanations about the group’s social reality with the goal of inducing a positive reaction that leads to a better perception of the received group recommendations. Among other challenges, we uncover a special need to focus on “tactful” explanations when addressing users’ personal relationships within a group and to focus on personalized reassuring explanations that encourage users to accept the presented recommendations. Besides, the resulting intelligent system significatively increases users’ intent (likelihood) to follow the recommendations, users’ satisfaction and the system’s efficiency and trustworthiness

    Aprendizaje de técnicas avanzadas de Programación Orientada a Objetos mediante programación de juegos

    Get PDF
    Los juegos constituyen un área muy adecuada para la elaboración de prácticas de programación. En muchos casos, permiten la aplicación directa de los contenidos teóricos impartidos en otras asignaturas teóricas, como las relacionadas con estructuras de datos y algoritmia. Además, al ser prácticas que se alejan de los típicos “problemas de juguete”, permiten introducir nuevas técnicas o tecnologías con demanda en el mundo laboral. En este artículo presentamos la experiencia realizada en un curso de Laboratorio de Programación III, en la que hemos propuesto la implementación de Sudokus en Java. Como veremos, el problema nos ha permitido poner en práctica conceptos de estructuras de datos y algoritmia, así como patrones de diseño y programación de dispositivos móviles

    Building case-based reasoning applications with myCBR and COLIBRI Studio

    Get PDF
    myCBR and COLIBRI Studio are two well-established opensource frameworks for building case-based reasoning (CBR) applications, though they follow different approaches and support different phases of the CBR application development. In a nutshell: Where myCBR supports its users in developing a knowledge model for representing cases, it more or less leaves the software developers alone when they try to develop an application that uses the generated knowledge model. COLIBRI Studio, on the other hand, is focused in the development of applications that use that knowledge model. As soon as you have a knowledge model COLIBRI Studio offers templates for a variety of application types and supports in generating its source code. This paper explains the strengths and weaknesses of both frameworks regarding the rapid development of CBR applications. It also shows how to use both of them in conjunction

    Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

    Get PDF
    Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

    Get PDF
    Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure &lt; 100 mmHg (n = 1127), estimated glomerular filtration rate &lt; 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

    MENTORIZATE-UCM: Herramientas de gestión del programa de mentorías en la UCM

    Get PDF
    El objetivo a largo plazo es el desarrollo de una aplicación informática que permita gestionar de forma más efectiva el programa de mentorías de reciente implantación en la UCM en toda la UCM. Este proyecto complementa el proyecto PIMCD #305 de esta convocatoria
    corecore